M E Whitcomb. Show Affiliations »
Abstract
Entities: Disease
Mesh： See more » Anti-Bacterial Agents/adverse effectsAnticoagulants/adverse effectsAntihypertensive Agents/adverse effectsBleomycin/adverse effectsBusulfan/adverse effectsChlorpropamide/adverse effectsCyclophosphamide/adverse effectsHemorrhage/chemically inducedHeroin/adverse effectsHumansHydrochlorothiazide/adverse effectsHypertension, Pulmonary/chemically inducedInhalationLeukemia, Lymphoid/drug therapyLipids/adverse effectsLung/pathologyLung Diseases/chemically inducedLung Diseases/pathologyMethotrexate/adverse effectsMethotrexate/therapeutic useMethysergide/adverse effectsNitrofurantoin/adverse effectsPhenytoin/adverse effectsPulmonary Edema/chemically induced
Substances： See more » Anti-Bacterial AgentsAnticoagulantsAntihypertensive AgentsLipidsHydrochlorothiazideBleomycinPhenytoinHeroinCyclophosphamideNitrofurantoinBusulfanChlorpropamideMethysergideMethotrexate
Year: 1973 PMID： 4120558 DOI： 10.1378/chest.63.3.418
Source DB: PubMed Journal: Chest ISSN： 0012-3692 Impact factor: 9.410